The news of British Land's agreement to buy Life Science REIT this week has got Bull & Bear talking about Life Sciences again.

Despite British Land's interest, Bear believes the sector is under a bit of pressure at the moment. Venture Capital investment levels are down and big pharma companies such as GSK and AstraZeneca are focusing investment away from the UK.
Bull thinks this may just be a passing phase, but both unequivocally agree that Government commitment to investing in the sector holds the key to kick-starting it again.